The global #CNS_Therapeutics_Market is growing substantially due to innovation in treating neurological and psychiatric disorders, increasing from USD 123.7 billion in 2025 to an expected USD 184.5 billion by 2033, with a CAGR of 5.3%. The Term CNS Therapeutics Market refers to medicines and treatments that target the central nervous system (CNS), which includes the brain and spinal cord. These therapeutics are designed to treat a wide range of neurological and psychiatric disorders by affecting how the CNS functions. Read More: https://m2squareconsultancy.com/reports/c-reactive-protein-testing-market